drugset / Trial / NCT04412850
Intravenous Magnesium Sulphate in Acute Ischemic Stroke
RandomizedParallel-groupSingle-blindTreatment
Summary
Magnesium has a neuroprotective role so the investigators aim to evaluate the role of intravenous magnesium sulphate in improving the clinical outcomes as assessed by the NIH Stroke Scale (NIHSS) in patients with acute ischemic stroke.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2021-06-01
- Completion
- 2021-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 16 g | Intravenous |